[PDF][PDF] Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis

CS Melincovici, AB Boşca, S Şuşman… - Rom J Morphol …, 2018 - rjme.ro
Vascular endothelial growth factor (VEGF) represents a growth factor with important pro-
angiogenic activity, having a mitogenic and an anti-apoptotic effect on endothelial cells …

VEGF targets the tumour cell

HL Goel, AM Mercurio - Nature Reviews Cancer, 2013 - nature.com
The function of vascular endothelial growth factor (VEGF) in cancer is not limited to
angiogenesis and vascular permeability. VEGF-mediated signalling occurs in tumour cells …

Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy

PS Chowdhury, K Chamoto… - Journal of internal …, 2018 - Wiley Online Library
Abstract Programmed death 1 (PD‐1) is an immune checkpoint molecule that negatively
regulates T‐cell immune function through the interaction with its ligand PD‐L1. Blockage of …

Distinct functions of neutrophil in cancer and its regulation

Z Granot, J Jablonska - Mediators of inflammation, 2015 - Wiley Online Library
Neutrophils are the most abundant of all white blood cells in the human circulation and are
usually associated with inflammation and with fighting infections. In recent years the role …

[HTML][HTML] Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?

YL Li, H Zhao, XB Ren - Cancer biology & medicine, 2016 - ncbi.nlm.nih.gov
Vascular endothelial growth factor (VEGF) is primarily known as a proangiogenic factor and
is one of the most important growth and survival factors affecting the vascular endothelium …

Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy

T Behl, A Kotwani - Pharmacological research, 2015 - Elsevier
Diabetic retinopathy, a sight-threatening microvascular complication of diabetes mellitus, is
initiated by retinal endothelial dysfunction and succeeded by various pathological events …

[HTML][HTML] Recent advances of nanotechnology-based tumor vessel-targeting strategies

D Zhu, Y Li, Z Zhang, Z Xue, Z Hua, X Luo… - Journal of …, 2021 - Springer
Tumor vessels can provide oxygen and nutrition for solid tumor tissue, create abnormal
tumor microenvironment (TME), and play a vital role in the development, immune escape …

VEGF and podocytes in diabetic nephropathy

A Tufro, D Veron - Seminars in nephrology, 2012 - Elsevier
Vascular endothelial growth factor-A (VEGF-A) is a protein secreted by podocytes that is
necessary for survival of endothelial cells, podocytes, and mesangial cells. VEGF-A …

Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond

K Mittal, J Ebos, B Rini - Seminars in oncology, 2014 - Elsevier
Our understanding of the dynamic tumor microenvironment (TME) has improved
exponentially over the last few decades. In addition to traditional cytotoxic agents, anti …

High-altitude adaptation in humans: from genomics to integrative physiology

P Azad, T Stobdan, D Zhou, I Hartley, A Akbari… - Journal of Molecular …, 2017 - Springer
Abstract About 1.2 to 33% of high-altitude populations suffer from Monge's disease or
chronic mountain sickness (CMS). Number of factors such as age, sex, and population of …